Bernard Fraisse Net Worth

Bernard Fraisse has an estimated net worth of $4.1 billion, according to Forbes Real-Time Billionaires, Bernard Fraisse profile (figures as of October 20, 2026). That is up from $2.1 billion in 2019.

Bernard Fraisse is a French businessman who founded and runs Fareva, one of the world's largest contract makers of medicines, household products and cosmetics. His full name is Bernard Robert Louis Fraisse, and he was born in August 1956. He lives in Paris and owns all of Fareva.

Fraisse trained as a mechanical engineer. After finishing his degree he worked as a salesman of chemicals, learning how the industry bought and sold the ingredients that go into everyday products. He then struck out on his own and built a manufacturing company that big brands trust to produce their goods.

He is known for guarding his independence. Fraisse refuses to take any private equity money and intends to keep Fareva in family hands. That choice sets him apart from many rivals in contract manufacturing, a field where buyout firms are active investors.

How Bernard Fraisse made his money

According to Forbes, Fraisse started his own business in 1990. In its first year the company brought in $4.5 million in revenue. Fareva grew by making products for other companies, from drugs to cleaning goods to beauty items, so that brand owners could focus on marketing while it handled the factories.

Over the years that model scaled up dramatically. Fareva is now the largest contract manufacturing organization in France. Headquartered in Luxembourg, it has 13,000 employees and 41 locations around the world. In 2022 it pulled in $2.1 billion in revenue. Because he owns the whole company, its growth flows straight into his fortune.

Contract manufacturing is a quiet but essential part of the economy. Many well known medicines and personal care products on store shelves are made by companies like Fareva rather than by the brands whose names appear on the box. Fraisse saw early that big brands would rather pay a trusted partner than run their own plants, and he built his business around that idea.

How Forbes has valued Bernard Fraisse

Forbes valued Fraisse at $2.1 billion in 2019 and $1.6 billion in 2020, then $2.1 billion again in 2021. His figure rose to $2.4 billion in both 2022 and 2023 and to $2.5 billion in both 2024 and 2025.

The big jump came in 2026, when Forbes roughly doubled his estimate to $4.9 billion on its World's Billionaires List. As of October 20, 2026, the Forbes real-time billionaires tracker showed $4.1 billion. As a private company owner, his figure depends on how Forbes values Fareva against listed peers in the drug and consumer goods manufacturing business.